News About: Pharm. Industry
Concerns mounting over for-profit foreign hospital inIFEZ
The government is seeking the revision of the Medical Law to allow Koreans full access to foreign medical facilities inside the Incheon Free Economic Zone (IFEZ) for the first five years after they open, in order to b...
Korea’s trade deficit for medicine narrows in 2009
The country’s trade imbalance in drugs topped $2.20 billion last year, compared with $2.68 billion in 2008, according to the report by the Korea Pharmaceutical Traders Association.
By finished products, exports sto...
Handok, Novartis Korea strengthen strategic alliance
Handok Pharm said it will co-market new oral treatment released by Novartis, called Galvusmet, a combination of vildagliptin and metformin, here in Korea.
To this end, Handok and Novartis Korea signed an agreement ...
Concerns rise among Korean drug makers
The domestic pharmaceutical sector is expected to face an inevitable blow with multinational drug companies taking a stronger hold of the local market if the Korean drug price reform is implemented in October.
Some...
Korean drug price reform will hurt pharmaceutical sector
Korea's pharmaceutical sector could lose up to 3 trillion won if the government’s drug price reform plan takes into effect this October, according to the Korea Pharmaceutical Manufacturers Association.
The estimate...
Collapse of local pharmaceutical industry is national disaster
Rep. Paik Won-woo of the main opposition Democratic Party said that the "collapse" of the Korean pharmaceutical industry could become a "national disaster."
He added that the Korean drug price reform is nothing but...
Green Cross to deliver successful flu combat program in WHO meeting
Green Cross Corporation’s present Lee Byung-gun will announce the company’s successful anti-influenza A results in World Health Organization Consultation on the Composition of Influenza Vaccine for the Northern Hemisp...
Government seeks anti-rebate policy in October
For doctors who choose to get a discount on drugs rather than receive what are widely known as "rebates" from pharmaceutical firms in return for prescribing or recommending their products, the government will provide ...
Drugmakers oppose new drug-pricing plan
Pharmaceutical companies are vehemently opposing to the government’s plan to provide doctors with incentives in terms of pricing, which was made public on February 16.
The Korea Pharmaceutical Manufacturers Associa...
New drug-pricing system upsets drugmakers
Korean pharmaceutical companies are now dumbfounded by the government’s bold plan to uproot rampant illegal rebate activities in the pharmaceutical industry.
Under the plan, the government will pay medical institut...
